Newsroom

Featured

Alvogen first to market with generic equivalent to Tamiflu® Powder for oral suspension

Alvogen is first to market and has received final approval for the generic equivalent to Tamiflu® (oseltamivir phosphate) 6 mg/ml powder for oral suspension

Read More
MEET MANAGEMENT

Highly experienced management team with a proven track record of achieving high growth and profitability.

Media Gallery

Download center for company logos and images.

MEDIA CONTACT

Halldor Kristmannsson 
Vice President
Organizational Development
Global Communications & Branding

Phone (354) 522-2900

Email
Connect on LinkedIn